An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.
How Many People Might Lose Medicaid When States Unwind Continuous Enrollment?
Healthy People 2030 Leveraging Healthy People to Advance Health Equity Health equity is the attainment of the highest level of health for all people. “Eliminate health disparities, achieve health equity, and attain health literacy to improve the health and well-being of all.”
In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it
The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming
This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.
‘Unbelievably good price’: KC-area pharmacy dispenses bargain medicine — and hope Go to article
Charitable Pharmacies of America organization member receives Health Equity grant
FDA approves 1 Year delay of Track & Trace requirements
Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Branson MO: My Neighbor’s Charitable Pharmacy (NCP) will open its doors at 1232 Branson Hills Parkway February of 2023
Three Healthcare Organizations Join Forces to Save Lives
NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.

